LEGOO ENDOVASCULAR OCCLUSION GEL

FDA Premarket Approval P110003 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Changes to the packaging configurations of the device.

DeviceLEGOO ENDOVASCULAR OCCLUSION GEL
Generic NameOccluder, Internal Vessel, Temporary
ApplicantGENZYME CORP.
Date Received2012-10-15
Decision Date2012-11-13
PMAP110003
SupplementS002
Product CodeOBC 
Advisory CommitteeCardiovascular
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address GENZYME CORP. 52 Binney Street cambridge, MA 02142

Supplemental Filings

Supplement NumberDateSupplement Type
P110003Original Filing
S004 2014-02-27 30-day Notice
S003 2012-10-19 30-day Notice
S002 2012-10-15 30-day Notice
S001 2011-11-15 135 Review Track For 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.